Neoplasm
RecruitingLong‑term Safety of Adagrasib with Drug Combination in Adults with Solid Tumors
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Adagrasib
- Sponsor:Bristol-Myers Squibb Services Unlimited Company
Rare diseases
Investigational molecules
Locations
Back to the Netherlands200 clinical trials in Breda, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The Netherlands
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on multiple myeloma, breast cancer, and leukemia treatments. Studies evaluate novel drug combinations and targeted therapies to improve patient outcomes.
Investigations include combination therapies and treatment discontinuation strategies for various cancer types.
Research focusing on coronary artery disease and post-procedural care, including innovative diagnostic techniques and antithrombotic strategies.
Emphasis on personalized treatment approaches and diagnostic accuracy improvement.
Clinical trials examining respiratory infections and chronic conditions, including vaccine development and asthma management strategies.
Focus on both preventive measures and treatment optimizations for respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.